EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Sort by

Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems

Legal status of the documentIn force

CELEX number:
32006R0816
Form:
Regulation
Author:
European Parliament, Council of the European Union
Date of document:
17/05/2006
Number of pages:
7

Commission Implementing Decision (EU) 2024/888 of 22 March 2024 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

C/2024/1783

Legal status of the documentIn force

CELEX number:
32024D0888
Form:
Implementing decision
Author:
European Commission, Directorate-General for Health and Food Safety
Date of document:
22/03/2024; Date of adoption

Case T-12/24: Action brought on 10 January 2024 — Ferring Pharmaceuticals v Commission

CELEX number:
62024TN0012
Form:
Judicial information
Author:
General Court
Date of document:
10/01/2024

Case T-61/23: Judgment of the General Court of 17 January 2024 — Ona Investigación v EUIPO — Formdiet (BIOPÔLE) (EU trade mark — Opposition proceedings — Application for the EU word mark BIOPÔLE — Earlier national word mark AGUA BIOPOLAR — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

CELEX number:
62023TA0061
Form:
Judicial information
Author:
General Court
Date of document:
17/01/2024

Joined Cases T-221/22 and T-242/22: Judgment of the General Court of 20 December 2023 — Pharmaselect International and OmniActive Health Technologies v EUIPO — OmniActive Health Technologies and Pharmaselect International (LUTAMAX) (EU trade mark — Revocation proceedings — EU word mark LUTAMAX — Genuine use of the mark — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001) — Obligation to state reasons — Article 94(1) of Regulation 2017/1001)

CELEX number:
62022TA0221
Form:
Judicial information
Author:
General Court
Date of document:
20/12/2023

Commission Implementing Regulation (EU) 2024/772 of 4 March 2024 granting a Union authorisation for the single biocidal product AEROCLEAN in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

C/2024/1301

Legal status of the documentIn force

CELEX number:
32024R0772
Form:
Implementing regulation
Author:
European Commission, Directorate-General for Health and Food Safety
Date of document:
04/03/2024; Date of adoption

Case T-1169/23: Action brought on 20 December 2023 — Interapothek/EUIPO — Q4 Media (miababy)

CELEX number:
62023TN1169
Form:
Judicial information
Author:
General Court
Date of document:
20/12/2023

Case C-520/23 P: Appeal brought on 10 August 2023 by UGA Nutraceuticals Srl against the judgment of the General Court (First Chamber) delivered on 28 June 2023 in Case T-495/22, UGA Nutraceuticals v EUIPO — BASF (OMEGOR)

CELEX number:
62023CN0520
Form:
Judicial information
Author:
Court of Justice
Date of document:
10/08/2023

Case C-521/23 P: Appeal brought on 10 August 2023 by UGA Nutraceuticals Srl against the judgment of the General Court (First Chamber) delivered on 28 June 2023 in Case T-496/22, UGA Nutraceuticals v EUIPO — BASF (OMEGOR VITALITY)

CELEX number:
62023CN0521
Form:
Judicial information
Author:
Court of Justice
Date of document:
10/08/2023

Dangerous substances – List of authorisation decisions taken by the EEA EFTA States in accordance with Article 44(5) of Regulation (EU) 528/2012 in the first half of 2023

CELEX number:
E2024G01153
Form:
Notice
Author:
Standing Committee of the EFTA States
Date of document:
25/01/2024; Date of publication
Sort by
2
Domain: All, EUROVOC descriptor: pharmaceutical product, Search language: German